Showing 1 - 2 results of 2 for search 'Matsunaga, H.' Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Author
  • Matsunaga, H.
Showing 1 - 2 results of 2 for search 'Matsunaga, H.', query time: 0.05s Refine Results
  1. 1
    Increase in Anticancer Drug-Induced Toxicity by Fisetin in Lung Adenocarcinoma A549 Spheroid Cells Mediated by the Reduction of Claudin-2 Expression
    Increase in Anticancer Drug-Induced Toxicity by Fisetin in Lung Adenocarcinoma A549 Spheroid Cells Mediated by the Reduction of Claudin-2 Expression
    by Eguchi, H., Endo, S., Ikari, A., Kimura, R., Matsunaga, H., Matsunaga, T., Yoshino, Y.
    Published 2022
    Call Number: Loading...
    Located: Loading...
    View Fulltext in Publisher
    Article
  2. 2
    Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation
    Slitrk2 deficiency causes hyperactivity with altered vestibular function and serotonergic dysregulation
    by Akagi, T., Aruga, J., Corbett, D., Fujita, W., Hashikawa, T., Katayama, K.-I, Kobayashi, K., Matsumoto, Y., Matsunaga, H., Morimura, N., Murphy, N.P, Nagao, S., Okamoto, T., Ornthanalai, V.G, Yamada, K.
    Published 2022
    Call Number: Loading...
    Located: Loading...
    View Fulltext in Publisher
    Article
Search Tools: Get RSS Feed — Email this Search

Related Subjects

Cell biology Molecular physiology Neuroscience anticancer drug toxicity claudin-2 fisetin lung adenocarcinoma

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...